← Open Payments lookup

RUPINDERJIT SAMRA: Open Payments

NPI 1912139114 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$781 in 9 payments from 6 companies in 2025. Trend: 2023 $118 · 2024 $670 · 2025 $781

Food & beverage: $781
CompanyPaymentsAmount
Tandem Diabetes Care, Inc.2$196
AstraZeneca Pharmaceuticals LP1$144
Novo Nordisk Inc1$123
ALK-Abello, Inc1$119
Alkermes, Inc.1$114
CORDIS US CORP.3$84

Products named: t:slim X2 Insulin Pump with Control-IQ, TEZSPIRE, VIVITROL, INFINITI, MYNX CONTROL VENOUS, MYNX CONTROL.

Industry payments across CA — which companies pay providers there.